John Stagg Selected Research

nucleotidase

11/2015	CD73 is associated with poor prognosis in high-grade serous ovarian cancer.
5/2012	CD73: a potent suppressor of antitumor immune responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Stagg Research Topics

Disease

66	Neoplasms (Cancer) 06/2022 - 09/2002
17	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2010
15	Breast Neoplasms (Breast Cancer) 01/2020 - 06/2007
9	Melanoma (Melanoma, Malignant) 01/2022 - 09/2002
5	Triple Negative Breast Neoplasms 01/2019 - 05/2013
4	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2015
4	Inflammation (Inflammations) 01/2019 - 01/2014
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 11/2015
3	Parkinson Disease (Parkinson's Disease) 05/2015 - 07/2014
3	Carcinogenesis 05/2012 - 06/2007
2	Lymphoma (Lymphomas) 10/2020 - 04/2011
2	Hypoxia (Hypoxemia) 10/2017 - 03/2014
2	Fibrosarcoma 10/2013 - 05/2012
2	Experimental Melanoma 06/2004 - 09/2002
1	Nevus (Nevi) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Necrosis 05/2021
1	Ascites 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Lymphatic Metastasis 01/2019
1	Streptococcal Infections (Streptococcal Infection) 01/2018
1	Pneumococcal Infections 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 03/2017
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2017
1	Autoimmune Diseases (Autoimmune Disease) 05/2015

Drug/Important Bio-Agent (IBA)

26	Adenosine (Adenocard)FDA LinkGeneric 06/2022 - 01/2010
12	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2019 - 01/2010
9	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2016
8	AntigensIBA 01/2022 - 03/2006
8	Monoclonal AntibodiesIBA 10/2020 - 01/2010
7	EnzymesIBA 01/2021 - 01/2010
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2006
4	Adenosine Triphosphate (ATP)IBA 06/2022 - 05/2012
4	CytokinesIBA 01/2021 - 09/2002
4	AntibodiesIBA 07/2017 - 05/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 09/2002
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2015
3	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2019 - 07/2014
3	Trastuzumab (Herceptin)FDA Link 10/2017 - 04/2011
3	Granzymes (Granzyme)IBA 05/2015 - 08/2011
3	Purinergic P1 Receptor AntagonistsIBA 05/2015 - 01/2010
3	Interleukin-2 (IL2)IBA 03/2006 - 06/2004
2	ectoATPaseIBA 06/2022 - 03/2014
2	Immune Checkpoint ProteinsIBA 10/2020 - 07/2017
2	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2016
2	LigandsIBA 01/2020 - 10/2008
2	Adenosine Monophosphate (AMP)IBA 01/2020 - 10/2013
2	Transcription Factors (Transcription Factor)IBA 10/2017 - 09/2002
2	Biological ProductsIBA 01/2017 - 01/2015
2	nucleotidaseIBA 11/2015 - 05/2012
2	VaccinesIBA 10/2014 - 12/2004
2	MethylcholanthreneIBA 10/2013 - 05/2012
2	PerforinIBA 09/2013 - 06/2007
2	Epidermal Growth Factor (EGF)IBA 04/2011 - 10/2008
2	OvalbuminIBA 04/2011 - 03/2006
2	InterleukinsIBA 12/2004 - 06/2004
1	CD3 ComplexIBA 01/2022
1	Interleukin-27 (Interleukin 27)IBA 01/2022
1	Carbon Nanotubes (Carbon Nanotube)IBA 05/2021
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2021
1	N(1)-methylnicotinamideIBA 01/2021
1	S-Adenosylmethionine (Ademetionine)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Nicotinamide N-MethyltransferaseIBA 01/2021
1	Rituximab (Mabthera)FDA Link 10/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	durvalumabIBA 01/2019
1	tremelimumabIBA 01/2019
1	NucleotidasesIBA 01/2019
1	Vascular Endothelial Growth Factor CIBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2018
1	23-valent pneumococcal capsular polysaccharide vaccineIBA 01/2018
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2018
1	Gemcitabine FDA Link 04/2017
1	Firefly LuciferasesIBA 04/2017
1	Chimeric Antigen ReceptorsIBA 03/2017
1	AutoantigensIBA 03/2017
1	Hormones (Hormone)IBA 01/2017
1	Purinergic Receptors (Receptors, Purine)IBA 01/2016
1	Polysaccharides (Glycans)IBA 12/2015
1	PhytochemicalsIBA 12/2015
1	Interleukin-12 (IL 12)IBA 12/2015
1	IntegrinsIBA 05/2015
1	Pharmaceutical PreparationsIBA 05/2015

Therapy/Procedure

28	Therapeutics 05/2021 - 04/2007
20	Immunotherapy 01/2021 - 06/2004
5	Drug Therapy (Chemotherapy) 01/2016 - 08/2010
1	Induced Hyperthermia (Thermotherapy) 05/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2020
1	Precision Medicine 01/2020
1	Microbubbles 01/2020
1	Prostatectomy (Retropubic Prostatectomy) 01/2019
1	Aftercare (After-Treatment) 07/2017
1	Injections 01/2016